Pharma strikes me as one of the industries that would benefit heavily from a few congressionally chartered nonprofits being booted up. Same employee comp (with cash substitutes for stock), same general structure, same incentives, but with a mandate to recycle profits back into new drug development rather than paying out to shareholders through buybacks, dividends, etc, all audited by a dedicated regulatory body to en…
Pharmaceuticals is a pretty capital intensive industry. Who's providing the capital? The government? Moreover, who's providing oversight? Congress? Given how dysfunctional the government is right now, and the tendency of government programs to turn into jobs/pork barrel programs (eg. F35), I'm skeptical that it's going to work out better.
Risk
Who takes the risk of exploring a drug candidate that literally no one can predict will succeed or fail?Let's imagine the Secretary of Drug Development testifying before Congress on why so many of his drugs didn't work. His best strategy is to only pursue safe bets.